SCHEMBL553331

SCHEMBL553331

COc1ccccc1C=Cc1ccc(-c2ccc(C=Cc3ccccc3OC)cc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 12/20 0.79
TRPA1 O75762 1/20 0.79
CYP1A1 P04798 6/20 0.70
CYP1A2 P05177 6/20 0.70
CYP1B1 Q16678 6/20 0.70
CYP19A1 P11511 2/20 0.69
ALOX5 P09917 1/20 0.58
PTGS1 P23219 1/20 0.58
PTGS2 P35354 1/20 0.58
TFEB P19484 1/20 0.53
KDM4E B2RXH2 1/20 0.51
RELA Q04206 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178754 1.00 NFE2L2 (0.79) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL29547034 1.00 NFE2L2 (0.79) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL9168164 0.94 NFE2L2 (0.88) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL9168170 0.94 NFE2L2 (0.88) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL26022019 0.92 NFE2L2 (0.67) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL713258 0.88 NFE2L2 (1.00) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL713256 0.88 NFE2L2 (1.00) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL700257 0.87 NFE2L2 (0.76) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL700256 0.87 NFE2L2 (0.76) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1
SCHEMBL28703245 0.87 NFE2L2 (0.76) NFE2L2TRPA1CYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230106029-A1 METHOD OF ASSESSING THE HOMOGENEITY OF PLASTICS ZBIGNIEW KOTULSKI ZAKL PRZETWORSTWA TWORZYW SZTUCZNYCH INGREMIO PESZEL (PL) 2023-04-06 US claimed
EP-4114891-A1 METHOD OF ASSESSING THE HOMOGENEITY OF PLASTICS Zbigniew Kotulski Zaklad Przetworstwa Tworzyw Sztucznych Ingremio - Peszel (PL) 2023-01-11 EP claimed
CN-113777881-A Solder resist resin composition, solder resist structure, dry film, and printed wiring board 韩国太阳油墨有限公司 2021-12-10 CN claimed
EP-1951939-B1 SPANDEX HAVING ENHANCED WHITENESS, AND FABRICS AND GARMENTS COMPRISING THE SAME INVISTA TECH SARL (CH) 2009-08-19 EP claimed
US-20090189168-A1 White Light Emitting Device LUMINOSO PHOTOELECTRIC TECHNOLOGY CO., LTD. (TW) 2009-07-30 US claimed
US-20090129053-A1 LIGHT-ENHANCED ELEMENT LUMINOSO PHOTOELECTRIC TECHNOLOGY CO. (TW) 2009-05-21 US claimed
US-7422649-B2 Method for recording information in luminescent compositions and uses thereof in articles of manufacture AMERICAN DYE SOURCE, INC. (CA) 2008-09-09 US claimed
US-20080064621-A1 Optically brightened aqueous compositions EASTMAN CHEMICAL COMPANY 2008-03-13 US claimed
US-20070174972-A1 SPANDEX HAVING ENHANCED WHITENESS, AND FABRICS AND GARMENTS COMPRISING THE SAME INVISTA NORTH AMERICA S.A R.I. (US) 2007-08-02 US claimed
US-20070159092-A1 Enhanced brightness light emitting device LUMINOSO PHOTOELECTRIC TECHNOLOGY CO., LTD. (TW) 2007-07-12 US claimed
US-20070159062-A1 Light-enhanced element LUMINOSO PHOTOELECTRIC TECHNOLOGY CO. 2007-07-12 US claimed
US-20070080635-A1 Light emitting device for visible light generation LUMINOSO PHOTOELECTRIC TECHNOLOGY CO. (TW) 2007-04-12 US claimed
US-20260137591-A1 COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS ICU MEDICAL INC (US) 2026-05-21 US disclosed
EP-3882702-B1 FLUORESCENT WHITE TONERS AND RELATED METHODS XEROX CORP (US) 2026-01-28 EP disclosed
EP-4680181-A1 MIXTURE, POLYMER, DENTAL POLYMER FOR 3D PRINTING AND MEDICAL PRODUCT THEREOF PRO3DURE MEDICAL GMBH (DE) 2026-01-21 EP disclosed
EP-3625294-B1 LUMINESCENT COMPOSITION HONEYWELL INT INC (US) 2025-12-10 EP disclosed
US-5110835-A Coated with hydroxyl-containing quaternary ammonium salt BASF AKTIENGESELLSCHAFT (DE) 1992-05-05 US disclosed
EP-0470455-A2 Antistatic expansible polystyrene pearls BASF Aktiengesellschaft (DE) 1992-02-12 EP disclosed
US-4094634-A Anionic and nonionic emulsified optical brightener suspension with a hydrotropic agent CIBA GEIGY AG (CH) 1978-06-13 US disclosed
US-4042320-A PRINTING, OPTICAL BRIGHTENERS CIBA-GEIGY AG (CH) 1977-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137591-A1 COMPOSITIONS AND DEVICES FOR CONTAINING MEDICAL FLUIDS TFEB, LAGE3, RICTOR NFE2L2 1018/4885TRPA1 392/4885CYP1A1 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.